Ascendis Pharma A (ASND) Tax Rate (2014 - 2026)
Ascendis Pharma A (ASND) reported Tax Rate of 1406.31% for Q1 2026, up 140517.0% on a YoY basis from N/an in Q1 2025, and up 5376.94% sequentially from 25.68% in Q4 2025.
Ascendis Pharma A (ASND) Tax Rate (2014 - 2026) Analysis & Trends
Ascendis Pharma A (ASND) has 13 years of Tax Rate data on file, last reported at 1406.31% in Q1 2026.
- For the quarter ending Q1 2026, Tax Rate rose 140517.0% year-over-year to 1406.31%; the trailing twelve-month figure through Mar 2026 stood at 417.0% (up 41600.0% YoY), and the FY2025 full-year result was 18.67%, down 1737.0% from the prior year.
- Tax Rate grew to 1406.31% in Q1 2026, from 25.68% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 1406.31% in Q1 2026 to a low of 0.35% in Q2 2023.
- A 5-year average of 86.33% and a median of 1.18% in 2023 frame the typical range for Tax Rate.
- Across the five-year window, Tax Rate sank 424 bps in 2024 and jumped 140517 bps in 2026, its largest moves.
- Tracing ASND's Tax Rate over 5 years: stood at 2.65% in 2022, then soared by 170 bps to 7.14% in 2023, then plunged by 59 bps to 2.9% in 2024, then surged by 785 bps to 25.68% in 2025, then soared by 5377 bps to 1406.31% in 2026.
- Business Quant data shows ASND's Tax Rate at 1406.31% in Q1 2026, 25.68% in Q4 2025, and 6.3% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.34% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.29% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -5.41% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 17.68% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 12.51% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 33.09% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ascendis Pharma A | 15.31 Bn | 14.64 Bn | 268.20 Mn | 1,406.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,406.31% |
| Mar 31, 2026 | 1,406.31% |
| Mar 31, 2026 | 1,406.31% |
| Dec 31, 2025 | 25.68% |
| Dec 31, 2025 | 25.68% |
| Dec 31, 2025 | 25.68% |
| Sep 30, 2025 | 6.30% |
| Sep 30, 2025 | 6.30% |
| Sep 30, 2025 | 6.30% |
| Jun 30, 2025 | 10.99% |
| Jun 30, 2025 | 10.99% |
| Jun 30, 2025 | 10.99% |
| Mar 31, 2025 | 1.13% |
| Mar 31, 2025 | 1.13% |
| Mar 31, 2025 | 1.13% |
| Dec 31, 2024 | 2.90% |
| Dec 31, 2024 | 2.90% |
| Dec 31, 2024 | 2.90% |
| Sep 30, 2024 | 1.04% |
| Sep 30, 2024 | 1.04% |